![Hans Arwidsson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hans Arwidsson
Presidente presso SPAGO NANOMEDICAL AB
Posizioni attive di Hans Arwidsson
Società | Posizione | Inizio | Fine |
---|---|---|---|
SPAGO NANOMEDICAL AB | Presidente | 10/05/2023 | - |
Healthy Bizniz Europe AB | Direttore/Membro del Consiglio | - | - |
Eurocince Securities AB
![]() Eurocince Securities AB Real Estate DevelopmentFinance Eurocince Securities AB is a Swedish company that manages fixed and movable property. The private company is based in Stockholm, Sweden. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Hans Arwidsson
Precedenti posizioni note di Hans Arwidsson
Società | Posizione | Inizio | Fine |
---|---|---|---|
Biosergen AS
![]() Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Amministratore Delegato | 01/01/2004 | 01/01/2007 |
Lipocore Holding AB | Amministratore Delegato | 01/01/2001 | 01/01/2003 |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 01/01/2001 | 01/01/2001 |
NANEXA AB | Direttore/Membro del Consiglio | 01/01/2016 | 01/01/2017 |
Presidente | 01/01/2017 | - | |
XSPRAY PHARMA AB | Direttore/Membro del Consiglio | 01/01/2006 | - |
Astra Pharmaceuticals AB | Corporate Officer/Principal | - | - |
░░░░░░░░ ░░░░░░░░ ░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░░░ | - | - |
Formazione di Hans Arwidsson
University of Uppsala | Graduate Degree |
Stockholm School of Economics | Masters Business Admin |
Statistiche
Distribuzione geografica
Svezia | 12 |
Norvegia | 2 |
Posizioni
Director/Board Member | 5 |
Chief Executive Officer | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
XSPRAY PHARMA AB | Health Technology |
NANEXA AB | Health Technology |
SPAGO NANOMEDICAL AB | Health Technology |
Aziende private | 7 |
---|---|
Eurocine Vaccines AB
![]() Eurocine Vaccines AB Pharmaceuticals: MajorHealth Technology Eurocine Vaccines AB engages in the research and development of nasal influenza vaccine for children and adult. Its technology, Endocine used to develop a patent protected nasal influenza vaccine for children. The company was founded in 1999 and is headquartered in Solna, Sweden. | Health Technology |
Astra Pharmaceuticals AB | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
Healthy Bizniz Europe AB | |
Lipocore Holding AB | |
Biosergen AS
![]() Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Health Technology |
Eurocince Securities AB
![]() Eurocince Securities AB Real Estate DevelopmentFinance Eurocince Securities AB is a Swedish company that manages fixed and movable property. The private company is based in Stockholm, Sweden. | Finance |
- Borsa valori
- Insiders
- Hans Arwidsson
- Esperienza